2,6-Dichloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol → HCID 66715655, compound

HRID 2271954Notes

Reaction equation

HRID 2271954 reaction equation
Br[C:2]1[CH:3]=[C:4]2[C:9](=[CH:10][CH:11]=1)[N:8]=[CH:7][C:6]([C:12]([CH:14]1[CH2:16][CH2:15]1)=[O:13])=[C:5]2[NH:17][C:18]1[CH:19]=[N:20][C:21]([CH2:24][N:25]([CH3:27])[CH3:26])=[CH:22][CH:23]=1.[Cl:28][C:29]1[CH:34]=[C:33](B2OC(C)(C)C(C)(C)O2)[CH:32]=[C:31]([Cl:44])[C:30]=1[OH:45]>>[CH:14]1([C:12]([C:6]2[CH:7]=[N:8][C:9]3[C:4]([C:5]=2[NH:17][C:18]2[CH:19]=[N:20][C:21]([CH2:24][N:25]([CH3:26])[CH3:27])=[CH:22][CH:23]=2)=[CH:3][C:2]([C:33]2[CH:34]=[C:29]([Cl:28])[C:30]([OH:45])=[C:31]([Cl:44])[CH:32]=2)=[CH:11][CH:10]=3)=[O:13])[CH2:15][CH2:16]1

Participants

3

Procedure

Following general procedure F, {6-bromo-4-[6-((dimethylamino)methyl)pyridin-3-ylamino]quinolin-3-yl}(cyclopropyl)methanone (37 mg, 0.087 mmol) was reacted with 2,6-dichloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol (38 mg, 0.131 mmol) to afford the desired product (25 mg, 57%) as a yellow solid: 1H NMR (500 MHz, CD3OD+TFA-d) δ 9.37 (s, 1H), 8.75 (s, 1H), 8.32 (dd, J=8.8, 2.1 Hz, 1H), 8.22 (d, J=2.1 Hz, 1H), 8.10 (d, J=8.8 Hz, 1H), 7.96 (dd, J=8.4, 2.6 Hz, 1H), 7.65 (d, J=8.4 Hz, 1H), 7.47 (s, 2H), 4.58 (s, 2H), 2.95 (s, 6H), 2.83-2.74 (m, 1H), 1.19-1.07 (m, 4H); ESI MS m/z 507 [C27H24Cl2N4O2+H]+; HPLC 98.9% (AUC), tR=10.66 min.

Sources & evidence

ORD record
ord-b78839257c4340458c788fae989cbf2f
Source dataset
uspto-grants-2015_09
Patent number
US09120749B2

Reaction notes

Loading…